(Total Views: 1068)
Posted On: 08/02/2020 5:20:05 PM
Post# of 149272
Re: reallypeople? #46698
With an 80% improvement in mortality over placebo and no SAEs attributable to leronlimab it would be a given the DSMB would want the trial shut down and data submitted to the FDA due to benefit.
(7)
(0)
Scroll down for more posts ▼